Apr 16, 2019 | Blog, News and Events, Staff Articles
Stem Cell Arts Dr. Mayo Friedlis has been invited to speak at the American Association of Orthopedic Medicine’s (AAOM) annual conference in Denver from May 1-4, 2019. Dr. Friedlis will lead a discussion on “Prolotherapy, PRP, Stem Cells – When to Use What?”
Dr. Friedlis was one of the first physicians in the Washington, D.C. area to be trained to perform platelet rich plasma (PRP) therapy and is one of the first doctors in the area to use stem cell therapy for musculoskeletal injuries. He has been performing these treatments on patients for 15 years. As such, he will share this vast experience with the hundreds of physicians, surgeons, researchers and other healthcare professionals who attend the annual AAOM conference to discuss the latest techniques and therapies in musculoskeletal pain medicine.
Dr. Friedlis performs the Regenexx® Family of Stem Cell and Platelet Procedures at Stem Cell Arts. Regenexx® Stem Cell therapy extracts the patient’s own stem cells (not amniotic or cord tissue cells) and concentrates these cells at the highest level possible. These cells are then reinjected into the injured area to boost the body’s ability to naturally promote healing. The result is relief from chronic pain and inflammation from conditions such as arthritis, herniated back discs, tendon tears or joint injuries. The entire treatment is conducted in Stem Cell Arts’ sterile, state-of-the-art office procedure suites and in house laboratory, and takes only a few hours.
Dr. Friedlis is a past president of the AAOM and currently serves on its Educational Committee. An advocate for global stewardship, Dr. Friedlis coordinated medical mission trips to Central Mexico each year that are sponsored by the AAOM. These trips provided much needed pain management services to poor, rural communities. In 2011, he directed a new medical outreach program that brought pain management services to Lima, Peru.
Despite having more than 25 years of experience in the field of pain medicine, Dr. Friedlis continually enhances his knowledge and expertise through continuing education, training and research. That is one of the reasons he has been recognized by his peers as one of WASHINGTONIAN Magazine’s Top Doctors in Pain Management.
Dr. Friedlis earned his medical degree from Wayne State University and was selected Chief Resident during his residency at Sinai Hospital in Detroit. He is board certified in Physical Medicine and Rehabilitation and is a Diplomat of the American Academy of Pain Management and the National Board of Medical Examiners. He has recently authored a book chapter on bone marrow aspiration to obtain stem cells for clinical use. He is an active member of the American Association of Orthopedic Medicine, American Academy of Pain Management, American Society of Interventional Pain Physicians, the International Spinal Injection Society and Virginia Medical Society.
Nov 15, 2018 | Blog, Regenerative Treatments, Staff Articles, Stem Cell Procedures
When Regenexx first started using mesenchymal stem cells (MSCs) to treat orthopedic problems in 2005, embryonic stem cells (ESCs) were king. However, a funny thing happened in 2010, when the number of research papers published on MSCs equaled the number published on ESCs. Since then, things have gotten much worse for embryonic stem cell research, and mesenchymal stem cell research is now clearly dominating the mesenchymal stem cell vs embryonic stem cell battle.
What Is an Embryonic Stem Cell?
Embryonic stem cells (ESC) are the cells that make a baby. They’re pluripotent, meaning that they have the ability to turn into all three cell types, which are ectoderm, endoderm, and mesoderm. Basically, they are stem cells that can turn into most cells of the human body.
What Is a Mesenchymal Stem Cell?
A mesenchymal stem cell is different. It’s a stem cell that’s found in adults (or really any individual past the age of embryo). It’s multipotent and can differentiate into a number of cell types that are of the mesodermal lineage. These include osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells), and adipocytes (fat cells). At StemCell ARTS we strictly only use the osteoblast which we obtain in the back pelvic area.
Mesenchymal Stem Cell vs Embryonic Stem Cell: Why MSC Research Surpassing ESC Research Is a Big Deal
The public was introduced to the concept of stem cells following a ban on embryonic stem cell research. This forced ESC researchers to take their case to the public. Scientists told the public that stem cells could be a possible cure for many incurable ailments. Unfortunately, along with the ethical problems associated with embryonic stem cells, it turned out that they also have a nasty little issue of causing teratomas (weird tumors). At the same time, many scientists began to recognize that stem cells could be found right in our own bodies in the form of mesenchymal stem cells. Hence, the race was on to see which stem cell type would become dominant. Mesenchymal stem cells are just more useful. They can be obtained from the patient without any ethical concerns and generally can do most of what ESCs can accomplish.
The upshot? Embryonic stem cell research is slowly dying off and being replaced by mesenchymal stem cell research. While this mesenchymal stem cell vs embryonic stem cell research reversal may have started because of the Bush administration ban, it’s accelerated since then because mesenchymal stem cells are just more practical as a therapy.
Mar 30, 2018 | Blog, Conditions, News and Events, Osteoarthritis, Procedure Outcomes, Regenerative Treatments, Research, Staff Articles
StemCell ARTS is part of a research consortium that includes clinics from around the globe. At the center, the Regenexx research lab. This location is the site of the research that provides the cutting edge procedures offered at the Regenexx affiliate locations. StemCell ARTS is proud to introduce another procedure being offered to help treat patients with musculoskeletal injuries or degenerative conditions.
Alpha-2-macroglobulin, referred to as A2M, is now available as a treatment option in both our Tysons Corner, VA and Chevy Chase, MD offices. A2M has been shown to provide benefit in those suffering from arthritic joints. Studies have indicated that A2M can reduce cartilage breakdown and inhibits a collagen breakdown protein involved in the progression of arthritis. This new and exciting treatment can be used in patients suffering from swelling of the joints and active patients looking to keep their joints healthy.
Could A2M help you? Read more about A2M from Regenexx’s own Dr. Centeno.
Mar 8, 2018 | Blog, News and Events, Procedure Outcomes, Staff Articles, Testimonials
Last month, the StemCell ARTS team attended the annual Interventional Orthopedics Foundation and Regenexx conference. The IOF annual conference focused on The Orthobiologic Singularity—a paradigm shift that will take orthopedic medicine from invasive to regenerative. The annual Regenexx conference brought together Regenexx Affiliates from around the globe, including Affiliate teams located in India, Taiwan, and Australia. This “meeting of the minds” provided a forum for the Regenexx Affiliates to learn more about what is to come with the Regenexx procedures. It also provided Regenexx Affiliates the opportunity to discuss and review best practices in each individual clinic.
The two day conference concluded with Regenexx handing out awards to the Affiliate teams. While a number of awards were given out to various clinics, StemCell ARTS took home, not only the most awards, but some of the most prestigious. StemCell ARTS won in the following categories:
- Most Thorough and Responsive Regenexx Patient Liaison
- Most Procedures Performed by a Group
- Most Procedures Performed by a Clinic (the big one!!)
Feb 1, 2018 | Staff Articles
For the month of February, we are offering free phone reviews with our regenerative physicians for patients who live a distance away from our Tysons Corner, Virginia or Chevy Chase, Maryland offices! Typically, the reviews are $200 to account for the physician’s time. These calls are about 30 minutes long, similar to an office visit. Imaging results, medical history, possible regenerative procedures and treatment plans are created during this time.
Once your candidacy is determined over the phone, our staff will be able to schedule you for a physical evaluation in the office with your physician, which is a visit that is submitted to your insurance. Plans will be finalized and treatments will begin the very same day!
If you are ready to send us your information, please review our website for locations and physicians.
Contact us at: (703)454-5972 with any further questions or concerns.
Jan 24, 2018 | Blog, News and Events, Regenerative Treatments, Staff Articles, Uncategorized
More and more physicians are offering regenerative procedures as treatment options in their practices. With so many physicians to choose from, how do patients determine what sets one regenerative medicine practice apart from another?
The physicians at StemCell ARTS go through extensive training to be part of the Regenexx network of physicians. The regenerative procedures, performed at StemCell ARTS, are all done with image guidance. That means all injections use fluoroscopy (x-ray) or ultrasound to determine exactly where the sample is being injected. The ability to perform image-guided injections requires additional knowledge, skill, and training.
The skill and expertise of the StemCell ARTS physicians has established them as the area’s foremost regenerative medicine experts in the field of interventional orthopedics. This reputation has earned both Dr. Rodney Dade, Dr. Mayo Friedlis and Dr. Robert Wagner the honor of being named Northern Virginia Magazine 2018 Top Doctors.